Workflow
Allist(688578)
icon
Search documents
艾力斯: 上海艾力斯医药科技股份有限公司关于2025年半年度利润分配方案的公告
Zheng Quan Zhi Xing· 2025-08-26 16:13
Profit Distribution Plan - The company plans to distribute a total profit of RMB 1,757,254,173.14, proposing a cash dividend of RMB 4.00 per 10 shares (including tax) to all shareholders, which represents 17.12% of the net profit attributable to shareholders for the first half of 2025 [1][2][3] - No bonus shares will be issued, and there will be no capital reserve fund conversion into share capital [1][3] Decision-Making Process - The board of directors approved the profit distribution plan during the 15th meeting of the second board on August 25, 2025, in accordance with the company's profit distribution policy [2] - The supervisory board also approved the profit distribution proposal, stating that it considers the company's operational performance, cash flow, and funding needs, and it aligns with legal regulations and the company's articles of association [2][3] Adjustments and Conditions - If there are changes in the total share capital due to convertible bonds, share buybacks, or other reasons before the record date for the dividend distribution, the total distribution amount will remain unchanged, but the per-share distribution ratio will be adjusted accordingly [1][3]
半年报汇总丨这家公司上半年净利润同比增超5900%
Di Yi Cai Jing· 2025-08-26 13:16
Growth - Shudao Equipment reported a net profit of 10.15 million yuan in the first half of the year, a year-on-year increase of 5972.30% [1] - Aerospace Science and Technology achieved a net profit of 88.97 million yuan, up 2161.91% year-on-year [1] - Tianbao Infrastructure's net profit reached 118 million yuan, growing by 2106.58% year-on-year [1] - Northern Rare Earth reported a net profit of 931 million yuan, an increase of 1951.52% year-on-year [1] - Liugang Co., Ltd. posted a net profit of 36.8 million yuan, up 579.54% year-on-year [1] - Cheng Tian Wei Ye's net profit was 10.88 million yuan, increasing by 562.05% year-on-year [1] - Perfect World reported a net profit of 503 million yuan, a year-on-year increase of 384.52% [1] - Shenghong Technology achieved a net profit of 2.143 billion yuan, up 366.89% year-on-year [1] - Zhongke Magnetic Industry's net profit was 20.90 million yuan, increasing by 271.78% year-on-year [1] - Xinjiang Communications Construction reported a net profit of 255 million yuan, up 255.25% year-on-year [1] - Shennong Group achieved a net profit of 388 million yuan, a year-on-year increase of 212.65% [1] - Daikin Heavy Industries reported a net profit of 547 million yuan, up 214.32% year-on-year [1] - Fostar's net profit was 251 million yuan, increasing by 140.45% year-on-year [1] - Guohua Airlines achieved a net profit of 1.24 billion yuan, up 86.15% year-on-year [1] - China Electric Port reported a net profit of 181 million yuan, increasing by 64.98% year-on-year [1] - Ailisi's net profit was 1.051 billion yuan, up 60.22% year-on-year [1] - Zijin Mining reported a net profit of 23.292 billion yuan, a year-on-year increase of 54.41% [1] - Zhongke Chuangda achieved a net profit of 158 million yuan, up 51.84% year-on-year [1] - Sichuan Gold reported a net profit of 209 million yuan, increasing by 48.41% year-on-year [1] - Dongxing Securities achieved a net profit of 819 million yuan, up 42.12% year-on-year [1] - Fosun Pharma reported a net profit of 1.702 billion yuan, a year-on-year increase of 38.96% [1] - Kotec Power's net profit was 23.99 million yuan, increasing by 35.52% year-on-year [1] - Dongshan Precision reported a net profit of 758 million yuan, up 35.21% year-on-year [1] - Inspur Information achieved a net profit of 799 million yuan, a year-on-year increase of 34.87% [1] - Shenzhen Huaqiang reported a net profit of 236 million yuan, increasing by 33.45% year-on-year [1] - Conch Cement achieved a net profit of 4.368 billion yuan, up 31.34% year-on-year [1] - Jiuzhoutong reported a net profit of 1.446 billion yuan, increasing by 19.7% year-on-year [1] - Aofei Data achieved a net profit of 87.89 million yuan, a year-on-year increase of 16.09% [2] Decline and Loss - Huachang Chemical reported a net profit of 1.09 million yuan, a year-on-year decrease of 97.58% [2] - Meibang Apparel achieved a net profit of 993,030 yuan, down 87.07% year-on-year [2] - Toukeng Life reported a net profit of 275,930 yuan, a decrease of 58.41% year-on-year [2] - BlueFocus reported a net profit of 96.44 million yuan, down 47.33% year-on-year [2] - China Gold achieved a net profit of 31.9 million yuan, a decrease of 46.35% year-on-year [2] - Huaxi Biological reported a net profit of 22.1 million yuan, down 35.38% year-on-year [2] - Zhejiang New Energy achieved a net profit of 29.2 million yuan, down 34.65% year-on-year [2] - Hainan Mining reported a net profit of 28.1 million yuan, a decrease of 30.36% year-on-year [2] - Changying Precision achieved a net profit of 30.6 million yuan, down 29.37% year-on-year [2] - China Duty Free reported a net profit of 2.6 billion yuan, down 20.81% year-on-year [2] - Jiangling Motors achieved a net profit of 73.3 million yuan, down 18.17% year-on-year [2] - Donghua Software reported a net profit of 24.4 million yuan, down 15.78% year-on-year [2] - Hengda New Materials achieved a net profit of 3.4235 million yuan, down 12.68% year-on-year [2] - Yaoji Technology reported a net profit of 25.6 million yuan, down 9.98% year-on-year [2] - Ping An Insurance achieved a net profit of 68.047 billion yuan, down 8.8% year-on-year [2] - China Petroleum reported a net profit of 840.07 billion yuan, down 5.4% year-on-year [2] - 360 reported a net loss of 28.2 million yuan [2] - Electric Wind Power reported a net loss of 27.9 million yuan [2] Losses - Suzhou Keda reported a net loss of 21.7 million yuan [3] - Yuntian Lifa achieved a net loss of 20.6 million yuan [3] - Kosen Technology reported a net loss of 10.5 million yuan [3] - Xinyada reported a net loss of 5.2635 million yuan [3] - Chengfei Integration achieved a net loss of 1.49208 million yuan [3] - China Film reported a net loss of 11 million yuan, turning from profit to loss year-on-year [3]
艾力斯:2025年半年度归属于上市公司股东的净利润同比增长60.22%
(编辑 何成浩) 证券日报网讯 8月26日晚间,艾力斯发布公告称,2025年半年度公司实现营业收入2,373,762,579.40 元,同比增长50.57%;归属于上市公司股东的净利润为1,051,235,341.42元,同比增长60.22%。 ...
艾力斯:第二届监事会第十二次会议决议公告
Zheng Quan Ri Bao· 2025-08-26 12:53
(文章来源:证券日报) 证券日报网讯 8月26日晚间,艾力斯发布公告称,公司第二届监事会第十二次会议审议通过了《关于公 司及其摘要的议案》等多项议案。 ...
艾力斯: 上海艾力斯医药科技股份有限公司第二届监事会第十二次会议决议公告
Zheng Quan Zhi Xing· 2025-08-26 09:22
本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 上海艾力斯医药科技股份有限公司(以下简称"公司")第二届监事会第十 二次会议于 2025 年 8 月 25 日在公司会议室召开。本次会议由监事会主席张晓芳 女士召集并主持,应到监事 3 人,实到监事 3 人;本次会议的召集和召开程序符 合《中华人民共和国公司法》等法律法规、规范性文件以及《公司章程》的相关 规定,会议形成的决议合法、有效。 二、监事会会议审议情况 证券代码:688578 证券简称:艾力斯 公告编号:2025-017 上海艾力斯医药科技股份有限公司 第二届监事会第十二次会议决议公告 (2)公司 2025 年半年度报告公允反映了报告期内的财务状况和经营成果, 所包含的信息从各个方面真实地反映出公司报告期内的经营管理和财务状况等 事项。公司 2025 年半年度报告所披露的信息真实、准确、完整,不存在虚假记 载、误导性陈述或重大遗漏; (3)提出本意见前,未发现参与半年度报告编制和审议的人员存在违反保 密规定的行为; (4)监事会全体成员保证公 ...
艾力斯(688578.SH)发布半年度业绩,归母净利润10.51亿元,同比增长60.22%
智通财经网· 2025-08-26 09:14
智通财经APP讯,艾力斯(688578.SH)披露2025年半年度报告,报告期公司实现营收23.74亿元,同比增 长50.57%;归母净利润10.51亿元,同比增长60.22%;扣非净利润9.05亿元,同比增长39.92%;基本每股收 益2.34元。公司拟每10股派发现金红利4.00元(含税)。 ...
艾力斯(688578) - 上海艾力斯医药科技股份有限公司关于公司2025年度“提质增效重回报”行动方案的半年度评估报告
2025-08-26 09:12
一、聚焦主营业务,强化公司核心竞争力 2025 年上半年度,公司以创新驱动发展,持续聚焦肿瘤治疗领域的药物 研发与科学探索,有效推进自主商业化,并着力提升科学治理水平。得益于这 些举措的有效实施,公司整体经营保持稳健发展的态势。 上海艾力斯医药科技股份有限公司关于 公司 2025 年度"提质增效重回报"行动方案的 半年度评估报告 为落实"以投资者为本"的发展理念,提高上市公司质量,增强投资者回 报,提升投资者的获得感,助力形成共建共享共担的资本市场新生态,基于对 公司未来发展前景的信心、价值的认可及为切实履行企业社会责任,上海艾力 斯医药科技股份有限公司(以下简称"公司")制定了 2025 年度"提质增效重 回报"行动方案,并于 2025 年 4 月 22 日经公司第二届董事会第十四次会议审 议通过。2025 年上半年,行动方案主要举措的落实进展及成效情况具体如下: 1、全力推进在研项目进度,持续拓宽肺癌研发管线 公司始终坚持以"创新"为核心竞争力,坚持实施创新驱动发展战略。2025 年上半年,公司围绕伏美替尼展开深度研发,积极拓展伏美替尼的临床价值和市 场竞争力。2025 年 1 月,伏美替尼对比安慰剂辅助 ...
艾力斯(688578) - 上海艾力斯医药科技股份有限公司2025年半年度募集资金存放与实际使用情况专项报告
2025-08-26 09:12
证券代码:688578 证券简称:艾力斯 公告编号:2025-018 上海艾力斯医药科技股份有限公司 2025年半年度募集资金存放与实际使用情况专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 根据《上市公司募集资金监管规则》、《上海证券交易所科创板上市公司自 律监管指引第1号——规范运作》和《上海证券交易所科创板股票上市规则》等有 关规定,上海艾力斯医药科技股份有限公司(以下简称"本公司"、"公司"或 "艾力斯")董事会对2025年半年度募集资金存放与实际使用情况专项报告说明 如下: 一、募集资金基本情况 根据中国证券监督管理委员会于2020年10月12日签发的证监许可[2020]2559号 文《关于同意上海艾力斯医药科技股份有限公司首次公开发行股票注册的批复》, 本公司在境内首次公开发行90,000,000股人民币普通股A股股票,每股发行价格为 人民币22.73元,股款以人民币缴足,计人民币2,045,700,000.00元,扣除承销及保 荐费用、律师费、审计验资费、信息披露费以及其他发行手续费共计人民币 11 ...
艾力斯:2025年半年度净利润约10.51亿元,同比增加60.22%
Mei Ri Jing Ji Xin Wen· 2025-08-26 08:43
Group 1 - The core viewpoint of the article highlights the significant growth in the financial performance of Ailis, with a reported revenue of approximately 2.374 billion yuan for the first half of 2025, representing a year-on-year increase of 50.57% [1] - The net profit attributable to shareholders of the listed company reached about 1.051 billion yuan, marking a year-on-year increase of 60.22% [1] - Basic earnings per share increased to 2.34 yuan, reflecting a year-on-year growth of 60.27% [1] Group 2 - As of the report, Ailis has a market capitalization of 42.8 billion yuan [2] - The pet industry is experiencing a significant boom, with a market size of 300 billion yuan, leading to a surge in stock prices for industry-listed companies [2]
艾力斯(688578.SH):上半年净利润10.51亿元,同比增长60.22%
Ge Long Hui A P P· 2025-08-26 08:37
Core Insights - The company reported a significant increase in revenue and net profit for the first half of 2025, with revenue reaching 2.374 billion yuan, a year-on-year growth of 50.57% [1] - Net profit attributable to shareholders was 1.051 billion yuan, reflecting a year-on-year increase of 60.22% [1] - The company plans to distribute a cash dividend of 4.00 yuan per 10 shares to all shareholders [1] Revenue Growth - The primary driver of revenue growth was the strong sales performance of the core product, Fumetinin tablets, which saw continuous sales expansion during the reporting period [1] Profitability - The net profit excluding non-recurring gains and losses was 905 million yuan, marking a year-on-year growth of 39.92% [1] - Basic earnings per share were reported at 2.34 yuan [1]